
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services has demonstrated a positive financial outlook, highlighted by a 190 basis points expansion in the Acute Care Services segment's same-store adjusted EBITDA margin to 15.8%. The company reported a 12.8% increase in same-store revenue for the acute segment, with a notable rise in revenue per adjusted admission by 9.8%, suggesting robust operational performance and patient engagement. Additionally, with pending CMS program approvals that could yield a $75-80 million benefit and a favorable 2026 outlook driven by strong pricing power, Universal Health Services appears well-positioned for sustained revenue growth.
Bears say
The analysis of Universal Health Services Inc reveals a negative outlook primarily due to anticipated volume and margin headwinds, with earnings projected to be approximately 5% below previous estimates for fiscal year 2026, resulting in a reduced enterprise multiple averaging 5.5x—indicative of trough levels. Furthermore, the company's long-term growth projections for its behavioral health segment have been lowered to a growth rate of 2-3%, alongside a forecasted decline in the DPP contribution to EBITDA starting in 2028, with potential financial impacts estimated between $420-470 million from 2028 to 2032. Additionally, external risks including regulatory changes, market concentration in Las Vegas, and labor supply constraints further threaten the productivity and profitability of the firm's operations.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares